Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D): Study rationale, design, and methods.

Donald C SimonsonBo HuDavid E ArterburnPhilip R SchauerSangeeta R KashyapAnita P CourcoulasDavid E CummingsMary Elizabeth PattiWilliam F GourashAshley H VernonJohn M JakicicJohn P Kirwan

Published in: Diabetes, obesity & metabolism (2022)

ARMMS-T2D will provide the largest body of long-term, level 1 evidence to inform clinical decision-making regarding the comparative durability, efficacy and safety of metabolic surgery relative to a medical/lifestyle intervention among patients with T2D, including those with milder class I obesity or mere overweight.

Keyphrases

type diabetes
weight loss
minimally invasive
coronary artery bypass
metabolic syndrome
decision making
insulin resistance
randomized controlled trial
physical activity
weight gain
cardiovascular disease
healthcare
surgical site infection
glycemic control
clinical trial
adipose tissue
atrial fibrillation